| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.700 | None | 0.975 | 1 | 2 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 6 | 4 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 2 | 1981 | 2014 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 3 | 43 | 1982 | 2018 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 4 | 2 | 1992 | 2019 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.848 | 4 | 2 | 2002 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1997 | 2017 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1992 | 2018 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.430 | None | 1.000 | 2 | 2 | 2005 | 2019 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.200 | None | 0.944 | 1 | 14 | 1993 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.962 | 4 | 7 | 1990 | 2016 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.470 | None | 1.000 | 2 | 5 | 2002 | 2014 | ||||||||
|
dipeptidyl peptidase 4 | 0.420 | 0.808 | 7.3E-09 |
|
disease | 0.190 | None | 0.900 | 1 | 1 | 2014 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.490 | None | 0.786 | 2 | 2 | 2003 | 2019 | ||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.110 | None | 1.000 | 2 | 3 | 2007 | 2011 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.480 | None | 1.000 | 1 | 1 | 1991 | 2017 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1996 | 2018 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 9 | 4 | 2004 | 2019 | ||||||||
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 0.938 | 3 | 62 | 1988 | 2020 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
disease | 0.170 | None | 1.000 | 1 | 1 | 2004 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 0.889 | 5 | 5 | 2000 | 2019 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.500 | None | 0.971 | 2 | 1 | 2001 | 2019 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
disease | 0.440 | None | 0.714 | 1 | 1 | 2008 | 2019 |